Haematologica (May 2017)
Deltex-1 mutations predict poor survival in diffuse large B-cell lymphoma
- Leo Meriranta,
- Annika Pasanen,
- Riku Louhimo,
- Alejandra Cervera,
- Amjad Alkodsi,
- Matias Autio,
- Minna Taskinen,
- Ville Rantanen,
- Marja-Liisa Karjalainen-Lindsberg,
- Harald Holte,
- Jan Delabie,
- Rainer Lehtonen,
- Sampsa Hautaniemi,
- Sirpa Leppä
Affiliations
- Leo Meriranta
- Research Programs Unit, Genome-Scale Biology Program, Faculty of Medicine, University of Helsinki, Finland;Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Finland
- Annika Pasanen
- Research Programs Unit, Genome-Scale Biology Program, Faculty of Medicine, University of Helsinki, Finland;Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Finland
- Riku Louhimo
- Research Programs Unit, Genome-Scale Biology Program, Faculty of Medicine, University of Helsinki, Finland
- Alejandra Cervera
- Research Programs Unit, Genome-Scale Biology Program, Faculty of Medicine, University of Helsinki, Finland
- Amjad Alkodsi
- Research Programs Unit, Genome-Scale Biology Program, Faculty of Medicine, University of Helsinki, Finland
- Matias Autio
- Research Programs Unit, Genome-Scale Biology Program, Faculty of Medicine, University of Helsinki, Finland;Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Finland
- Minna Taskinen
- Research Programs Unit, Genome-Scale Biology Program, Faculty of Medicine, University of Helsinki, Finland;Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Finland
- Ville Rantanen
- Research Programs Unit, Genome-Scale Biology Program, Faculty of Medicine, University of Helsinki, Finland
- Marja-Liisa Karjalainen-Lindsberg
- Department of Pathology, Helsinki University Hospital, Finland
- Harald Holte
- Department of Oncology, Oslo University Hospital, Norway
- Jan Delabie
- Department of Pathology, University of Toronto, ON, Canada;Department of Pathology, Oslo University Hospital, Norway
- Rainer Lehtonen
- Research Programs Unit, Genome-Scale Biology Program, Faculty of Medicine, University of Helsinki, Finland
- Sampsa Hautaniemi
- Research Programs Unit, Genome-Scale Biology Program, Faculty of Medicine, University of Helsinki, Finland
- Sirpa Leppä
- Research Programs Unit, Genome-Scale Biology Program, Faculty of Medicine, University of Helsinki, Finland;Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Finland
- DOI
- https://doi.org/10.3324/haematol.2016.157495
- Journal volume & issue
-
Vol. 102,
no. 5
Abstract
No abstracts available.